A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation

Jyotsna Pandya, Rodion Gorchakov, Eryu Wang, Grace Leal, Scott Weaver

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To develop an effective vaccine against eastern equine encephalitis (EEE), we engineered a recombinant EEE virus (EEEV) that was attenuated and capable of replicating only in vertebrate cells, an important safety feature for live vaccines against mosquito-borne viruses. The subgenomic promoter was inactivated with 13 synonymous mutations and expression of the EEEV structural proteins was placed under the control of an internal ribosomal entry site (IRES) derived from encephalomyocarditis virus (EMCV). We tested this vaccine candidate for virulence, viremia and efficacy in the murine model. A single subcutaneous immunization with 104 infectious units protected 100% of mice against intraperitoneal challenge with a highly virulent North American EEEV strain. None of the mice developed any signs of disease or viremia after immunization or following challenge. Our findings suggest that the IRES-based attenuation approach can be used to develop a safe and effective vaccine against EEE and other alphaviral diseases.

Original languageEnglish (US)
Pages (from-to)1276-1282
Number of pages7
JournalVaccine
Volume30
Issue number7
DOIs
StatePublished - Feb 8 2012

Fingerprint

Eastern equine encephalitis virus
Eastern Equine Encephalomyelitis
Vaccines
viremia
encephalitis
vaccines
viruses
Viremia
immunization
Encephalomyocarditis virus
horses
Immunization
structural proteins
mice
live vaccines
Viral Structural Proteins
Culicidae
virulence
animal models
vertebrates

Keywords

  • Alphavirus
  • Attenuation
  • Eastern equine encephalitis virus
  • RNA virus
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation. / Pandya, Jyotsna; Gorchakov, Rodion; Wang, Eryu; Leal, Grace; Weaver, Scott.

In: Vaccine, Vol. 30, No. 7, 08.02.2012, p. 1276-1282.

Research output: Contribution to journalArticle

Pandya, Jyotsna ; Gorchakov, Rodion ; Wang, Eryu ; Leal, Grace ; Weaver, Scott. / A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation. In: Vaccine. 2012 ; Vol. 30, No. 7. pp. 1276-1282.
@article{fa6e4bafcf984b25b595df95fb289b80,
title = "A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation",
abstract = "To develop an effective vaccine against eastern equine encephalitis (EEE), we engineered a recombinant EEE virus (EEEV) that was attenuated and capable of replicating only in vertebrate cells, an important safety feature for live vaccines against mosquito-borne viruses. The subgenomic promoter was inactivated with 13 synonymous mutations and expression of the EEEV structural proteins was placed under the control of an internal ribosomal entry site (IRES) derived from encephalomyocarditis virus (EMCV). We tested this vaccine candidate for virulence, viremia and efficacy in the murine model. A single subcutaneous immunization with 104 infectious units protected 100{\%} of mice against intraperitoneal challenge with a highly virulent North American EEEV strain. None of the mice developed any signs of disease or viremia after immunization or following challenge. Our findings suggest that the IRES-based attenuation approach can be used to develop a safe and effective vaccine against EEE and other alphaviral diseases.",
keywords = "Alphavirus, Attenuation, Eastern equine encephalitis virus, RNA virus, Vaccine",
author = "Jyotsna Pandya and Rodion Gorchakov and Eryu Wang and Grace Leal and Scott Weaver",
year = "2012",
month = "2",
day = "8",
doi = "10.1016/j.vaccine.2011.12.121",
language = "English (US)",
volume = "30",
pages = "1276--1282",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "7",

}

TY - JOUR

T1 - A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation

AU - Pandya, Jyotsna

AU - Gorchakov, Rodion

AU - Wang, Eryu

AU - Leal, Grace

AU - Weaver, Scott

PY - 2012/2/8

Y1 - 2012/2/8

N2 - To develop an effective vaccine against eastern equine encephalitis (EEE), we engineered a recombinant EEE virus (EEEV) that was attenuated and capable of replicating only in vertebrate cells, an important safety feature for live vaccines against mosquito-borne viruses. The subgenomic promoter was inactivated with 13 synonymous mutations and expression of the EEEV structural proteins was placed under the control of an internal ribosomal entry site (IRES) derived from encephalomyocarditis virus (EMCV). We tested this vaccine candidate for virulence, viremia and efficacy in the murine model. A single subcutaneous immunization with 104 infectious units protected 100% of mice against intraperitoneal challenge with a highly virulent North American EEEV strain. None of the mice developed any signs of disease or viremia after immunization or following challenge. Our findings suggest that the IRES-based attenuation approach can be used to develop a safe and effective vaccine against EEE and other alphaviral diseases.

AB - To develop an effective vaccine against eastern equine encephalitis (EEE), we engineered a recombinant EEE virus (EEEV) that was attenuated and capable of replicating only in vertebrate cells, an important safety feature for live vaccines against mosquito-borne viruses. The subgenomic promoter was inactivated with 13 synonymous mutations and expression of the EEEV structural proteins was placed under the control of an internal ribosomal entry site (IRES) derived from encephalomyocarditis virus (EMCV). We tested this vaccine candidate for virulence, viremia and efficacy in the murine model. A single subcutaneous immunization with 104 infectious units protected 100% of mice against intraperitoneal challenge with a highly virulent North American EEEV strain. None of the mice developed any signs of disease or viremia after immunization or following challenge. Our findings suggest that the IRES-based attenuation approach can be used to develop a safe and effective vaccine against EEE and other alphaviral diseases.

KW - Alphavirus

KW - Attenuation

KW - Eastern equine encephalitis virus

KW - RNA virus

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84856560156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856560156&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.12.121

DO - 10.1016/j.vaccine.2011.12.121

M3 - Article

VL - 30

SP - 1276

EP - 1282

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 7

ER -